{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T08:26:42Z","timestamp":1751012802651,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR1\/8812\/COE\/34\/01\/2017"],"award-info":[{"award-number":["BT\/PR1\/8812\/COE\/34\/01\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2020-7548\/CMB-BMS)."],"award-info":[{"award-number":["2020-7548\/CMB-BMS)."]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-02007-8","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T13:13:20Z","timestamp":1680614000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["YAP transduction drives triple-negative breast cancer aggressiveness through modulating the EGFR\u2012AKT axis in patient-derived xenograft cells"],"prefix":"10.1007","volume":"40","author":[{"given":"Sulfath Thottungal","family":"Parambil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhosh Kumar R.","family":"Thankayyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisha Rose","family":"Antony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajeesh Babu","family":"Littleflower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Augustine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thara","family":"Somanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1916-0015","authenticated-orcid":false,"given":"Lakshmi","family":"Subhadradevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"2007_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/npjbcancer.2016.36","volume":"2","author":"F Pareja","year":"2016","unstructured":"Pareja F, Geyer FC, Marchi\u00f2 C, Burke KA, Weigelt B, Reis-Filho JS. Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants. NPJ breast cancer. 2016;2:1\u201311. https:\/\/doi.org\/10.1038\/npjbcancer.2016.36.","journal-title":"NPJ breast cancer"},{"key":"2007_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/path.4280","volume":"232","author":"BD Lehmann","year":"2014","unstructured":"Lehmann BD, Pietenpol JA. Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes. J Pathol. 2014;232:142\u201350. https:\/\/doi.org\/10.1002\/path.4280.","journal-title":"J Pathol"},{"key":"2007_CR3","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1016\/j.clbc.2017.07.013","volume":"18","author":"KK Thakur","year":"2018","unstructured":"Thakur KK, Bordoloi D, Kunnumakkara AB. Alarming burden of triple-negative breast cancer in India. Clin Breast Cancer. 2018;18:e393\u20139. https:\/\/doi.org\/10.1016\/j.clbc.2017.07.013.","journal-title":"Clin Breast Cancer"},{"key":"2007_CR4","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1200\/GO.20.00054","volume":"6","author":"A Kulkarni","year":"2020","unstructured":"Kulkarni A, Kelkar DA, Parikh N, Shashidhara LS, Koppiker CB, Kulkarni MJ. Meta-analysis of prevalence of triple-negative breast cancer and its clinical features at incidence in Indian patients with breast cancer. JCO Glob Oncol. 2020;6:1052\u201362. https:\/\/doi.org\/10.1200\/GO.20.00054.","journal-title":"JCO Glob Oncol"},{"key":"2007_CR5","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130:1120\u201333. https:\/\/doi.org\/10.1016\/j.cell.2007.07.019.","journal-title":"Cell"},{"key":"2007_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19:491\u2013505. https:\/\/doi.org\/10.1016\/j.devcel.2010.09.011.","journal-title":"Dev Cell"},{"key":"2007_CR7","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00005.2014","author":"S Piccolo","year":"2014","unstructured":"Piccolo S, Dupont S, Cordenonsi M. The biology of YAP\/TAZ: hippo signaling and beyond. Physiol Rev. 2014. https:\/\/doi.org\/10.1152\/physrev.00005.2014.","journal-title":"Physiol Rev"},{"key":"2007_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan K-L, Development. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1\u201317. https:\/\/doi.org\/10.1101\/gad.274027.115.","journal-title":"Genes Dev"},{"key":"2007_CR9","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, Wei X, Li W, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21:2747\u201361. https:\/\/doi.org\/10.1101\/gad.1602907.","journal-title":"Genes Dev"},{"key":"2007_CR10","doi-asserted-by":"publisher","first-page":"12405","DOI":"10.1073\/pnas.0605579103","volume":"103","author":"M Overholtzer","year":"2006","unstructured":"Overholtzer M, Zhang J, Smolen GA, et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. PNAS. 2006;103:12405\u201310. https:\/\/doi.org\/10.1073\/pnas.0605579103.","journal-title":"PNAS"},{"key":"2007_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi M, Zanconato F, Azzolin L, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 2011;147:759\u201372. https:\/\/doi.org\/10.1016\/j.cell.2011.09.048.","journal-title":"Cell"},{"key":"2007_CR12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1101\/gad.192856.112","volume":"26","author":"Y Liu-Chittenden","year":"2012","unstructured":"Liu-Chittenden Y, Huang B, Shim JS, et al. Genetic and pharmacological disruption of the TEAD\u2013YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 2012;26:1300\u20135.","journal-title":"Genes Dev"},{"key":"2007_CR13","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/cdd.2008.108","volume":"15","author":"M Yuan","year":"2008","unstructured":"Yuan M, Tomlinson V, Lara R, et al. Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ. 2008;15:1752\u20139.","journal-title":"Cell Death Differ"},{"key":"2007_CR14","first-page":"11248","volume":"8","author":"HM Kim","year":"2015","unstructured":"Kim HM, Jung WH, Koo JS. Expression of Yes-associated protein (YAP) in metastatic breast cancer. Int J Clin Exp Pathol. 2015;8:11248.","journal-title":"Int J Clin Exp Pathol"},{"key":"2007_CR15","first-page":"27","volume":"6","author":"C Wang","year":"2016","unstructured":"Wang C, Zhu X, Feng W, et al. Verteporfin inhibits YAP function through up-regulating 14-3-3\u03c3 sequestering YAP in the cytoplasm. Am J Cancer. 2016;6:27.","journal-title":"Am J Cancer"},{"key":"2007_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07555-0","volume":"20","author":"C Wei","year":"2020","unstructured":"Wei C, Li X. Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation. BMC Cancer. 2020;20:1\u20138. https:\/\/doi.org\/10.1186\/s12885-020-07555-0.","journal-title":"BMC Cancer"},{"key":"2007_CR17","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/cmdc.201700063","volume":"12","author":"F Gibault","year":"2017","unstructured":"Gibault F, Bailly F, Corvaisier M, et al. Molecular features of the YAP inhibitor verteporfin: synthesis of hexasubstituted dipyrrins as potential inhibitors of YAP\/TAZ, the downstream effectors of the hippo pathway. ChemMedChem. 2017;12:954\u201361. https:\/\/doi.org\/10.1002\/cmdc.201700063.","journal-title":"ChemMedChem"},{"key":"2007_CR18","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367\u201374. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0220.","journal-title":"Clin Cancer Res"},{"key":"2007_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1042\/BST20191055","volume":"48","author":"S Lev","year":"2020","unstructured":"Lev S. Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochem Soc Trans. 2020;48:657\u201365. https:\/\/doi.org\/10.1042\/BST20191055.","journal-title":"Biochem Soc Trans"},{"key":"2007_CR20","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/annonc\/mdn710","volume":"20","author":"B Corkery","year":"2009","unstructured":"Corkery B, Crown J, Clynes M, O\u2019Donovan N. Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer. Ann Oncol. 2009;20:862\u20137. https:\/\/doi.org\/10.1093\/annonc\/mdn710.","journal-title":"Ann Oncol"},{"key":"2007_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3892\/or_00000238","volume":"21","author":"H Nogi","year":"2009","unstructured":"Nogi H, Kobayashi T, Suzuki M, et al. EGFR as paradoxical predictor of chemosensitivity and outcome among triple-negative breast cancer. Oncol Rep. 2009;21:413\u20137. https:\/\/doi.org\/10.3892\/or_00000238.","journal-title":"Oncol Rep"},{"key":"2007_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.gendis.2019.11.003","volume":"8","author":"MR Zinatizadeh","year":"2021","unstructured":"Zinatizadeh MR, Miri SR, Zarandi PK, Chalbatani GM, Rap\u00f4so C, Mirzaei HR, Akbari ME, Mahmoodzadeh H. The hippo tumor suppressor pathway (yap\/taz\/tead\/mst\/lats) and egfr-ras-raf-mek in cancer metastasis. Genes Dis. 2021;8:48\u201360. https:\/\/doi.org\/10.1016\/j.gendis.2019.11.003.","journal-title":"Genes Dis"},{"key":"2007_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1200\/jco.19.00368","volume":"38","author":"P Schmid","year":"2020","unstructured":"Schmid P, Abraham J, Chan S, et al. Capivasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer: the PAKT trial. J Clin Oncol. 2020;38:423\u201333. https:\/\/doi.org\/10.1200\/jco.19.00368.","journal-title":"J Clin Oncol"},{"key":"2007_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0795-2","volume":"37","author":"W Xu","year":"2018","unstructured":"Xu W, Yang Z, Xie C, et al. PTEN lipid phosphatase inactivation links the hippo and PI3K\/Akt pathways to induce gastric tumorigenesis. J Exp Clin Cancer Res. 2018;37:1\u201316. https:\/\/doi.org\/10.1186\/s13046-018-0795-2.","journal-title":"J Exp Clin Cancer Res"},{"key":"2007_CR25","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.2147\/OTT.S157058","volume":"11","author":"C Wei","year":"2018","unstructured":"Wei C, Wang Y, Li X, Therapy. The role of Hippo signal pathway in breast cancer metastasis. OncoTargets Ther. 2018;11:2185. https:\/\/doi.org\/10.2147\/OTT.S157058.","journal-title":"OncoTargets Ther"},{"key":"2007_CR26","doi-asserted-by":"publisher","first-page":"E2441","DOI":"10.1073\/pnas.1212021109","volume":"109","author":"JM Lamar","year":"2012","unstructured":"Lamar JM, Stern P, Liu H, Schindler JW, Jiang Z-G, Hynes RO. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. PNAS. 2012;109:E2441\u201350. https:\/\/doi.org\/10.1073\/pnas.1212021109.","journal-title":"PNAS"},{"key":"2007_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.chembiol.2012.07.005","volume":"19","author":"E Miller","year":"2012","unstructured":"Miller E, Yang J, DeRan M, et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem Biol. 2012;19:955\u201362. https:\/\/doi.org\/10.1016\/j.chembiol.2012.07.005.","journal-title":"Chem Biol"},{"key":"2007_CR28","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.4161\/cc.22322","volume":"11","author":"F-X Yu","year":"2012","unstructured":"Yu F-X, Mo J-S, Guan K-L. Upstream regulators of the Hippo pathway. Cell Cycle. 2012;11:4097. https:\/\/doi.org\/10.4161\/cc.22322.","journal-title":"Cell Cycle"},{"key":"2007_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","volume":"150","author":"F-X Yu","year":"2012","unstructured":"Yu F-X, Zhao B, Panupinthu N, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780\u201391. https:\/\/doi.org\/10.1016\/j.cell.2012.06.037.","journal-title":"Cell"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02007-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T04:10:19Z","timestamp":1682655019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02007-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2007"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02007-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"assertion":[{"value":"20 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is approved by the Institutional Review Board of Regional Cancer Centre, Trivandrum-India.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the individuals participated in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participations"}},{"value":"The consent to publish the generated data is approved by all authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publications"}}],"article-number":"137"}}